However, another study found the opposite: lower serum levels of IGF-1 in patients with CLL (Binet stage A) than in a control group, and no significant correlation between serum IGF-1 levels and clinical and hematological variables (including the Rai stage) [161] (Table 1). The gene discussed is IGF1; the disease is B-cell chronic lymphocytic leukemia.